An ideal new agent will provide durable blood glucose-lowering efficacy that is better than or similar to that of available agents, carry minimal risk of overt hypoglycaemia, facilitate weight control and hopefully provide some further advantages, particularly against associated morbidities
There is evidence that once an AOM is stopped, even with an adjunct lifestyle program, patients regained 6.9% of the weight lost (8)
Common Side Effects and Safety Concerns with GLP-1 Therapy The most frequent side effects of GLP-1 medications occur in the gastrointestinal system and typically diminish over time
[DOI] [PubMed] [Google Scholar] Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, and Meader N (2021) New generation antidepressants for depression in children and adolescents: a network meta-analysis
Long-Term Outcomes: Will It Grow Back